WKWissam Kamal

Wissam Kamal

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Wissam Kamal has a total of 142 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    How do we choose the optimal length of flexible and navigable suction ureteral access sheaths (FANS): an EAU endourology and AUSET prospective multicenter analysis

    by Steffi Kar Kei Yuen, Daniele Castellani, Albert El Hajj, Bokye Soebhali, Deepak Ragoori, Khi Yung Fong, Chu Ann Chai, Chinnakhet Ketsuwan, Geavlete Petrisor, Mehmet Ilker Gokce, et al.

    Purpose: To evaluate how to assess the optimal length of flexible and navigable suction ureteral access sheaths (FANS) to be used during flexible ureteroscopy (FURS) for kidney stones. Methods: A prospective multicenter study (16 centers, July 2024–January 2025) enrolled 226 adults with normal renal anatomy undergoing FURS with FANS for renal stones. Three preoperative measurements were analyzed: (1) Subjective on X-ray: T12–pubic symphysis, (2) Objective on CT: upper pole–pubic symphysis, and (3) Dynamic ureteral catheter length with retrograde pyelogram (RPG): upper pole–urethral meatus. Sheath length appropriateness (too short/correct/too long) was assessed intraoperatively using predefined criteria (complete calyceal access, ergonomics, need for ancillary techniques). Secondary outcomes included 30-day stone-free rates (SFR) and complications. Results: Sheath length was deemed correct in 63.7%, too short in 9.7%, and too long in 26.5% of cases. For both genders, dynamic measurement of ureteric catheter length from upper pole calyx to 5 cm beyond the urethral meatus demonstrated the strongest correlation with optimal length ( R = 0.7). Gender-specific formulas for optimal FANS length were derived: Male: 0.52 × ureteral catheter length + 26 cm. Female: 1.2 × ureteral catheter length − 2.1 cm. Compensatory techniques for length discrepancies included assistant-held stabilization of FANS (28.3%) and telescoping of penis (3.5%). 96% of sheaths accessed all calyces. The 30-day SFR was 92.5% (Grade A: 79.2% zero fragments; Grade B: 13.3% fragments ≤ 2 mm). Complications were low: sepsis not requiring ICU admission (0.4%) and ureteric stricture (0.6%). Only 2.7% patients were planned for reintervention. Conclusion: The selection of an optimal FANS length is critical for optimizing outcomes in FURS. Dynamic RPG-ureteral catheter length measurement best predicts this, enabling gender-specific formulas for easy estimation. Our results provide valuable insights into the clinical relevance of preoperative measurements, intraoperative adjustments, and the impact of sheath length on procedural success and complications.


  • International Alliance of Urolithiasis (IAU) guidelines on the management of pediatric urolithiasis

    by G. Zeng, W. Zhu, B. Somani, S. Choong, M. Straub, M. V. Maroccolo, W. Kamal, T. A. A. Ibrahim, A. Cho, G. Mazzon, et al.

    The aim of this study was to develop the sixth set of guidelines in a series produced by the International Alliance of Urolithiasis (IAU), providing a clinical framework for the management of paediatric patients with urolithiasis based on the best available published evidence. All recommendations were synthesised following a systematic review and critical appraisal of the literature indexed in the PubMed database from January 1952 to December 2023. Each recommendation was graded according to a modified GRADE methodology. The guidelines were ratified by Panel Members after thorough review and discussion of the evidence. The recommendations address key topics including aetiology, risk factors, clinical presentation and symptoms, diagnosis, conservative management, surgicalinterventions, prevention, and follow-up. Notable parallels exist in the management of primary stone episodes between paediatric and adult patients, particularly regarding conservative treatment approaches and technological advancements facilitating less invasive stone removal. Additionally, preventive strategies aimed at reducing recurrence – such as adequate hydration, well-structured dietary modifications, and the selective use of pharmacological therapies – are anticipated to yield favourable outcomes in paediatric stone formers. Given the variability in the severity of metabolic abnormalities and anatomical anomalies, a meticulously planned, close follow-up programme is essential for each paediatric patient to mitigate the risk of future recurrences.

  • Open Access

    Reporting the Impact of Pelvicalyceal System (PCS) Anatomy on Clinical Outcomes in Retrograde Intrarenal Surgery (RIRS) Studies: Can We Do Better? – Methodological Review from the Section of EAU Endourology

    by Ali Talyshinskii, Yerkebulan Mukhambetov, Ulanbek Zhanbyrbekuly, Lazaros Tzelves, Patrick Juliebø-Jones, Theodoros Tokas, Giorgio Bozzini, Wissam Kamal, Bhaskar Kumar Somani

    To analyze available randomized clinical trials (RCTs) comparing retrograde intra renal surgery (RIRS) with other modalities for urinary stone treatment to determine the extent of comparing the pelvicalyceal system (PCS) anatomy between patients. In December 2024, a search was conducted in databases and was limited to publica tions that describe comparisons of experimental and control groups in the context of RIRS for stones only in the kidney (PCS). Only RCTs comparing RIRS with other modali ties without publication date restriction were included due to their highest level of evidence in the hierarchy of primary research. The parameters used in the selected studies were analyzed to compare the differences between the groups, focusing on PCS anatomy. The final analysis included 27 publications from 2421 articles. The pres ence and/or degree of hydronephrosis were analyzed in 8 studies. Direct morphomet ric measurements were compared in 4 studies and were focused on the lower pole only, namely the infundibulopelvic angle, infundibular length, and infundibular width. Features such as the position of the renal pelvis in relation to the kidney parenchyma (intrarenal, extrarenal), number and orientation of calyces, as well as the existing PCS classifications were not compared or used. This review shows gaps in the literature while assessing and reporting on PCS anatomy in studies with RIRS. Unless studies mention these anatomical factors without excluding certain groups of patients, it is difficult to compare outcomes between modalities a


  • Does intraoperative surgeon reported stone free status (IO-SFS) correlate with CT based post operative stone free status (PO-SFS) in flexible ureteroscopy using flexible and navigable suction ureteral access sheath (FANS) in real-world practice? A prospective global FANS collaborative study group initiative with the section of EAU endourology

    by Vineet Gauhar, Olivier Traxer, Steffi Kar Kei Yuen, Daniele Castellani, Guohua Zeng, Khi Yung Fong, Zhu Wei, Deepak Reddy Ragoori, Mohamed Elshazly, Kremena Petkova, et al.

    Background Flexible and navigable suction ureteral access sheath (FANS) has been proven to improve stone-free rate (SFR) and many studies report high intraoperative 100% stone-free status (IO-SFS) and postoperative 100% stone-free status (PO-SFS). The reliability of IO-SFS vis-à-vis image-proven PO-SFS needs to be evaluated as it has implications on perioperative management. Methods Our prospective, multicenter study enrolled 704 adult patients from 21 centers who underwent FURS with FANS between August 2023 and October 2024. IO-SFS was categorized into three groups: (1) 100% SFR (no dust or fragments), (2) only dust remaining, and (3) both dust and fragments remaining. PO-SFS was assessed via 2 mm non-contrast computed tomography (NCCT) at 30 days and categorized into four grades: Grade A (100% stone-free), Grade B (single ≤ 2 mm residual fragment), Grade C (single 2.1–4 mm), and Grade D (multiple or any > 4 mm). Primary outcome was correlation between intraoperative and postoperative 100% SFS. Secondary outcomes included perioperative complications, reintervention rates, and predictors of residual fragments and perioperative complications. Results IO-SFS reported 100% SFR in 395 cases. Postoperative NCCT confirmed a significantly higher SFS (Grade A + B) in this group (99%) compared to 95.8% in the dust only group and 61.1% in the dust and fragments group (p < 0.001). Positive predictive value (PPV) of intraoperative 100% SFR was 99% with post-op NCCT, while negative predictive value (NPV) was only 12.3%. Secondary outcome analysis showed higher stone volumes, lower pole locations, and use of high-power holmium lasers were associated with increased 2–4 mm residual fragments (OR 6.53, p = 0.047). In the 100% SFR group, the use of 12/14 Fr UAS and disposable scopes was significantly higher, with a preferred strategy combining fragmentation, dusting, and aspiration. No cases of sepsis or significant postoperative bleeding were reported due to the use of FANS, with fewer patients requiring post-operative stenting. Conclusion This study provides robust evidence that surgeon-reported 100% IO-SFS is highly predictive of NCCT-proven postoperative stone-free outcomes, with a PPV of 99%. However, intraoperative detection of residual fragments is less reliable in predicting persistent stone burden, as only 40% of these patients eventually achieved SFS on NCCT. Standardized imaging protocols remain necessary to optimize postoperative management and patient counseling, while avoid unnecessary re-intervention.


  • Multicenter outcome analysis of different sheath sizes for Flexible and Navigable Suction ureteral access sheath (FANS) ureteroscopy: an EAU Endourology collaboration with the global FANS study group

    by Jia-Lun Kwok, Bhaskar Somani, Kemal Sarica, Steffi Kar Kei Yuen, Marek Zawadzki, Daniele Castellani, Satyendra Persaud, Chu Ann Chai, Wissam Kamal, Tzevat Tefik, et al.

    Flexible and navigable suction ureteral access sheath (FANS) is a potential game changer in flexible ureteroscopy (FURS). The influence of sheath size on outcomes needs research. The primary aim was to analyze 30-day single stage stone free status (SFS), zero fragment rate (ZFR) and complications when using 10/12Fr sheaths vis a vis other sheath sizes. The global FANS research group published the 30-day outcomes in patients who underwent FANS and reasoned this can be a potential game changer. We included 295 patients from this anonymized dataset with division into two groups: Group 1 (Smaller sheath) – 10/12Fr FANS, and Group 2 (Larger sheath) – 11/13Fr or 12/14Fr sheaths. Stone volume was similar between both groups (median 1320 mm3, p = 0.88). Ureteroscopy and total operative time was longer in the smaller sheath group (35 vs. 32 min, p = 0.02 and 50 vs. 45 min, p = 0.001, respectively). While 30-day computed tomography SFS (100% stone free or single residual fragment ≤ 2 mm) were not significantly different (96% vs. 95%, p > 0.99), ZFR (100% stone-free) was better with smaller sheaths (68% vs. 53%, p = 0.02). There was no difference in postoperative complication rates, and no sepsis in both groups. Urologists should consider individualizing appropriate sheath size in normal adult kidneys. Sheath size did not affect complication rates, risk of perioperative injury to the pelvicalyceal system or ureteric injury, but smaller FANS sheaths had similar high SFS. The ZFR with smaller sheaths was better, but this needs to be validated. These smaller sheath outcomes need to be balanced with longer ureteroscopy time, operative time, reach to the lower pole, ease of suction and visibility during lithotripsy. Large volume studies in different types of pelvicalyceal anatomy can determine if indeed smaller FANS is the best choice in FURS.


  • Challenges in diagnosis and treatment of cystinuria patients with Urolithiasis: multicenter patient centered study

    by Wissam Khalid Kamal, Mohammed Abuzenada, Raed A. Azhar, Musab M. Alghamdi, Hassan Aljifri, Yahya Ghazwani, Aiman Al Solumany, Saeed Bin Hamri, Ahmad Bugis, Abdulaziz Almanie, et al.

    Introduction and aim Cystinuria represents a rare cause of urolithiasis, accounting for 1% of all cases. However, it poses unique challenges in diagnosis and management. This study aimed to examine the challenges of managing cystine stones from the perspective of cystinuria patients. Methods Following ethical approval, we reviewed the medical records of cystine stone patients treated at four tertiary centers from 2016 to 2021 and surveyed them on their perceptions of cystinuria. It included questions about demographic characteristics, herbal treatments, pain management, online engagement, disease outcomes, and cystinuria-related fears. Results The study included 28 adults with cystinuria nephrolithiasis, with a mean age of 30.5 years. Of these, 78.6% had consanguineous parents, and the first stone episode occurred at a mean of 14.82 years age. Family history of Cystinuria was encountered in 82.1%. Cystinuria was diagnosed after a mean of 6.43 years from the first stone episode, and stone analysis was performed in 22/28 after a mean of 3.86 years from the first stone episode. Only 17 patients (60.8%) underwent metabolic evaluation for kidney stones. Regarding non-surgical treatments, 13 (46.5%) patients received alkalinization medication, and only 10 (35.7%) were prescribed chelating agent therapy. Additionally, 50% of patients took herbal remedies. Conclusion The diagnosis of cystinuria is often delayed, leading to a delay in receiving medical treatment (alkalinization and chelating agents) and poor health education and counseling. Thus, referring cystinuria patients to tertiary hospitals and providing a multidisciplinary approach might decrease the morbidity of the disease and enhance their well-being.


  • Open Access

    The impact of urolithiasis on urology services in a high-prevalence region: A multicenter study

    by Wissam Khalid Kamal, Musab M. Alghamdi, Raed A. Azhar, Ahmad Bugis, Mohammed Abuzenada, Majed Alharthi, Saeed Bin Hamri, Yahya Ghazwani, Yasser A. Noureldin, Hassan Aljifri, et al.


  • Open Access

    Utilization of barley and parsley for the management of urolithiasis among the Saudi Arabian population

    by Wissam Khalid Kamal, Akram Bokhari, Saud M. Alesia, Tamer Ma Mahjari, Wajdi A. Binsalman, Abdullah E. Laher, Ahmed Adam

    Objective: To determine the utilization of barley and parsley for managing urolithiasis among the Saudi Arabian population. Methods: This is a prospective cross-sectional survey-based study. The survey comprised questions about the use of barley, parsley, and other therapies for managing urolithiasis. A WhatsApp® message with the link to the study survey was sent out to family, friends, patients, and other acquaintances residing in the Kingdom of Saudi Arabia (KSA). Results: A total of 1014 respondents completed the survey, of which 44.8% indicated that they utilized barley, 38.3% stated that they used parsley, and 4.2% indicated that they utilized other non-medical remedies to treat or prevent kidney stones. In contrast, only 29.5% stated that they utilized potassium citrate and/or magnesium citrate, and only 14.4% indicated that they consumed greater amounts of water to treat or prevent kidney stones. Conclusion: Our study findings indicate that among the Saudi Arabian population, non-conventional therapies such as barley and parsley are more commonly utilized for managing urolithiasis rather than established therapies such as increasing water intake and the use of potassium-citrate/ magnesium-citrate. There is a need to conduct large-scale clinical studies to evaluate the efficacy and safety of barley, parsley, and other non-conventional therapies for treating urolithiasis.


  • Open Access

    The Saudi urological association guidelines on urolithiasis

    by Wissam Kamal, Raed A Azhar, Saeed Bin Hamri, Abdulaziz H. Alathal, Abdulaziz Alamri, Tarek Alzahrani, Hussain Abeery, Yasser A. Noureldin, Mohammad Alomar, Abdulrahman Al Own, et al.

    Aims: The Saudi Urolithiasis Guidelines are a set of recommendations for diagnosing, evaluating, and treating urolithiasis in the Saudi population. These guidelines are based on the latest evidence and expert consensus to improve patient outcomes and optimize care delivery. They cover the various aspects of urolithiasis, including risk factors, diagnosis, medical and surgical treatments, and prevention strategies. By following these guidelines, health-care professionals can improve care quality for individuals with urolithiasis in Saudi Arabia. Panel: The Saudi Urolithiasis Guidelines Panel consists of urologists specialized in endourology with expertise in urolithiasis and consultation with a guideline methodologist. All panelists involved in this document have submitted statements disclosing any potential conflicts of interest. Methods: The Saudi Guidelines on Urolithiasis were developed by relying primarily on established international guidelines to adopt or adapt the most appropriate guidance for the Saudi context. When necessary, the panel modified the phrasing of recommendations from different sources to ensure consistency within the document. To address areas less well covered in existing guidelines, the panel conducted a directed literature search for high quality evidence published in English, including meta analyses, randomized controlled trials, and prospective nonrandomized comparative studies. The panel also searched for locally relevant studies containing information unique to the Saudi Arabian population. The recommendations are formulated with a direction and strength of recommendation based on GRADE terminology and interpretation while relying on existing summaries of evidence from the existing guidelines.


  • Papillary versus non papillary puncture in percutaneous nephrolithotomy: A prospective randomized trial

    by P. Kallidonis, I. Kyriazis, D. Kotsiris, P. Ntasiotis, A. Koutava, V. Panagopoulos, W. Kamal, E. Liatsikos